Corporate consolidation stories

Aug 3, 2026

Supernus Pharmaceuticals and Indivior Pharmaceuticals Agree to All-Stock Merger Creating $2.2 Billion CNS Drug Company

Supernus Pharmaceuticals and Indivior Pharmaceuticals announced an all-stock merger to create a combined company with approximately $2.2 billion in annual revenue and a portfolio of 11 commercialized medicines focused on neurological, psychiatric, and addiction-related conditions. The deal, described as a merger of equals, is expected to generate $125 million in cost savings.

Aug 3, 20269 sources

Jul 23, 2026

DOJ speeds up merger reviews by reducing information requests

The Justice Department announced it will fast-track merger investigations by significantly reducing the amount of information requested from companies, marking a major shift in antitrust enforcement under the Trump administration.

Jul 23, 20262 sources